Skip to content

Clinical trials

Migraine Disorders trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Migraine Disorders Country / region: United Kingdom Clear all

57 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20064
20072
20082
20091
20113
20121
20132
20155
20161
20173
20182
20198
20205
20213
20225
20232
20243
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35
Terminated10
Recruiting3
Active, not recruiting3
Withdrawn3
Unknown status2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company6
AbbVie5
Pfizer5
Amgen4
Cumbria Partnership NHS Foundation Trust4
Allergan3
Barts & The London NHS Trust2
Boston Scientific Corporation2
ElectroCore INC2
H. Lundbeck A/S2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Migraine Disorders57
Headache15
Epilepsy4
Recurrence4
Pain3
Anxiety Disorders2
Cluster Headache2
Headache Disorders, Primary2
Heart Failure2
Hypertension2

Trials

Showing 1 to 25 of 57. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.